Home/Filings/4/0001171843-23-005892
4//SEC Filing

MYERS ROBERT L 4

Accession 0001171843-23-005892

CIK 0001446159other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 6:25 PM ET

Size

7.0 KB

Accession

0001171843-23-005892

Insider Transaction Report

Form 4
Period: 2023-09-25
MYERS ROBERT L
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-25+1,6675,230 total
  • Tax Payment

    Common Stock

    2023-09-25$2.96/sh510$1,5104,720 total
Footnotes (3)
  • [F1]On September 23, 2020, the Reporting Person was granted 5,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
  • [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
  • [F3]510 shares of common stock withheld by the Company on September 25, 2023 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.

Documents

1 file

Issuer

Predictive Oncology Inc.

CIK 0001446159

Entity typeother

Related Parties

1
  • filerCIK 0001553600

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:25 PM ET
Size
7.0 KB